Lindsay R. L. et al. (2006)
Journal of Intellectual and Developmental Disability
December, 31(4), pp. 204-209.
Lofthouse N. et al. (2012)
A review of complementary and alternative treatments for autism spectrum disorders.
Autism Research and Treatment
Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
American Journal of Psychiatry
161(6), pp. 1125-1127
McCracken J. T. et al. (2002)
Risperidone in children with autism and serious behavioral problems.
New England Journal of Medicine
347(5), pp. 314-321
McDougle C. J. et al. (2000)
Child and Adolescent Psychiatric Clinics of North America
January, 9(1), pp. 201-224.
Nikolov R. N. et al. (2009)
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.
Journal of Autism and Developmental Disorders
39(3), pp. 405-413
Scahill L. et al. (2006)
A prospective open trial of guanfacine in children with pervasive developmental disorders.
Journal of Child and Adolescent Psychopharmacology
16(5), pp. 589-598.
Scahill L. et al. (2012)
Journal of the American Academy of Child and Adolescent Psychiatry
51(2), pp. 136-146
Scahill L. et al. (2001)
Journal of Child and Adolescent Psychopharmacology
Winter, 11(4), pp, 377-88.
Scahill L. et al. (2017)
Journal of Child and Adolescent Psychopharmacology
March, 27(2), pp. 125-131.
Scahill L. et al. (2016)
Journal of the American Academy of Child and Adolescent Psychiatry
May, 55(5), pp. 415-423.
Journal of the Canadian Academy of Child and Adolescent Psychiatry
October, 55(10),
Vasa R. A. et al. (2016)
Assessment and treatment of anxiety in youth with autism spectrum disorders.
Pediatrics
February, 137
Vitiello B. et al. (2005)
Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone.
Journal of Clinical Psychopharmacology
25(6), pp. 565-569